ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Water → 2,2,2-Trifluoro-N-{6-[3-(4-methoxy-3-methyl-benzoyl)-4-oxo-4H-quinolin-1-ylmethyl]-pyridin-2-yl}-acetamide

HRID 227007
印刷

反応式

HRID 227007 の反応式
C[Si](C)(C)N[Si](C)(C)C.[K].[CH3:11][O:12][C:13]1[CH:31]=[CH:30][C:16]([C:17]([C:19]2[C:28](=[O:29])[C:27]3[C:22](=[CH:23][CH:24]=[CH:25][CH:26]=3)[NH:21][CH:20]=2)=[O:18])=[CH:15][C:14]=1[CH3:32].Br[CH2:34][C:35]1[N:40]=[C:39]([NH:41][C:42](=[O:47])[C:43]([F:46])([F:45])[F:44])[CH:38]=[CH:37][CH:36]=1.O>O1CCCC1.C(OCC)(=O)C>[F:46][C:43]([F:44])([F:45])[C:42]([NH:41][C:39]1[CH:38]=[CH:37][CH:36]=[C:35]([CH2:34][N:21]2[C:22]3[C:27](=[CH:26][CH:25]=[CH:24][CH:23]=3)[C:28](=[O:29])[C:19]([C:17](=[O:18])[C:16]3[CH:30]=[CH:31][C:13]([O:12][CH3:11])=[C:14]([CH3:32])[CH:15]=3)=[CH:20]2)[N:40]=1)=[O:47]
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 962WaterHCID 45051783Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, potassium saltHCID 57754672N-(6-bromomethyl-pyridin-2-yl)-2,2,2-trifluoro-acetamideHCID 577547583-(4-Methoxy-3-methyl-benzoyl)-1H-quinolin-4-one

生成物 1

HCID 577547792,2,2-Trifluoro-N-{6-[3-(4-methoxy-3-methyl-benzoyl)-4-oxo-4H-quinolin-1-ylmethyl]-pyridin-2-yl}-acetamide
収率 173.9%

試薬・触媒・溶媒 2

HCID 8028Tetrahydrofuran溶媒HCID 8857Ethyl Acetate溶媒

実験手順

Potassium hexamethyldisilazane (2.44 mL, 1.22 mmol, 0.5 M in THF) was added to a solution of 3-(4-Methoxy-3-methyl-benzoyl)-1H-quinolin-4-one (0.30 g, 1.02) in 10 mL of tetrahydrofuran. After the reaction was stirred at rt for 20 minutes, N-(6-Bromomethyl-pyridin-2-yl)-2,2,2-trifluoro-acetamide (0.35 g, 0.246 mmol) was added and stirred overnight at room temperature. Water and ethyl acetate were added and the two phases were separated. The aqueous phase was extracted with ethyl acetate (3×20 mL). The combined organic layers were dried with magnesium sulfate, filtered and concentrated in vacuo. The crude brown solid was purified by reverse phase HPLC with a C18 column, gradient of 20-70% acetonitrile—0.1% TFA to yield 212 mg of 2,2,2-Trifluoro-N-{6-[3-(4-methoxy-3-methyl-benzoyl)-4-oxo-4H-quinolin-1-ylmethyl]-pyridin-2-yl}-acetamide

後処理

  1. stirringstirred overnight at room temperature
  2. customthe two phases were separated
  3. extractionThe aqueous phase was extracted with ethyl acetate (3×20 mL)
  4. dry with materialThe combined organic layers were dried with magnesium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated in vacuo
  7. customThe crude brown solid was purified by reverse phase HPLC with a C18 column, gradient of 20-70% acetonitrile—0.1% TFA

出典と根拠

ORDレコード
ord-5f6f8193a68d4a29bb42c0a7c9495ae6
出典データセット
uspto-grants-2009_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07557213B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート